List of IVDs that have received WHO Emergency Use Listing for SARS-CoV-2 updated
IVD
Macleods’ Pyrimethamine/Sulfadoxine + Amodiaquine (hydrochloride) dispersible tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
The following APIs were added:
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C published
M
New Invitation for Expression of Interest (EOI) to manufacturers and suppliers of medicinal products for treatment of hepatitis B and C.